• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

XS Financial Announces Closing of California Lenders License Acquisition

Share:

July 20, 2020

XS Financial Inc. a specialty finance company engaged in equipment leasing in the United States, announced today that it has closed the acquisition of a California Lenders License (‘CFL”), through the purchase of a local entity (the “Target Company”), in California as previously announced (see press release dated January 27, 2020). The Company has issued today, 450,671 subordinate voting shares (“common shares”) of XS at a price of $0.29 per share, subject to a 12-month lockup, and made a cash payment of US$13,651 in consideration of the acquisition of all of the issued and outstanding shares of the Target Company.
The acquisition of the lender license allows XS to significantly expand its lending and financing capabilities in the state of California (“CA”). The Company expects the license to play a crucial role given the steady increase in inbound requests from customers with business operations in CA.

David Kivitz, Chief Executive Officer of XS, commented, “We are thrilled to have obtained our California Lenders License. It is estimated that California will represent as much as one in four of all dollars spent in the U.S. on legal cannabis by 2024. While once very fragmented, we are seeing the emergence of true manufactures in the market and will continue to assist growth with quality operators.”

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • General Cannabis Announce Entry into Term Sheet For Strategic AcquisitionGeneral Cannabis Announce Entry into Term Sheet For Strategic Acquisition
  • Microsoft and CVS Health Partner to Accelerate Personalized Care ExperienceMicrosoft and CVS Health Partner to Accelerate Personalized Care Experience
  • Health tech Startup Sami Raises $18M and More Digital Health Fundings.Health tech Startup Sami Raises $18M and More Digital Health Fundings.
  • CareMetx, General Atlantic and The Vistria Group Announce Strategic Growth PartnershipCareMetx, General Atlantic and The Vistria Group Announce Strategic Growth Partnership
  • Global Viral Conjunctivitis Pipeline Drugs Market 2021 Latest Insights, COVID 19 Impact Analysis, Growth Rate, Future Trends and Forecast to 2026Global Viral Conjunctivitis Pipeline Drugs Market 2021 Latest Insights, COVID 19 Impact Analysis, Growth Rate, Future Trends and Forecast to 2026
  • Sanofi Pushes Further Into Immuno-Oncology with $2.5 Billion Synthorx TakeoverSanofi Pushes Further Into Immuno-Oncology with $2.5 Billion Synthorx Takeover
  • Friendship Hospital for Animals Partners with Encore Vet GroupFriendship Hospital for Animals Partners with Encore Vet Group
  • Why the Digital Front Door is Critical to the Healthcare Revenue CycleWhy the Digital Front Door is Critical to the Healthcare Revenue Cycle

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications